Data from clinical studies In an observational study involving 20 diabetic subjects receiving background metformin therapy, exenatide treatment over 16 weeks resulted in improved flow-mediated vasodilation of the brachial artery following 5 min of forearm ischemia, as assessed by ultrasound echocardiography, compared to patients treated with glimepiride [85]
Aim for at least 8 to 10 cups of water daily, and adjust your intake based on your activity level and climate
A 2023 study suggested nearly four times higher risk
It's part of a new generation of drugs that help people lose weight by targeting multiple hormonal pathways that control appetite, metabolism, and energy balance
No safety issues were identified in the CRL, nor did the FDA request any additional studies be conducted, according to Endpoints News
Among members who were taking a GLP-1 at the time they were surveyed, less than a third indicated that they expected to be on the medication for the foreseeable future." Compare that to almost half of members who selected until I reach a target weight or other outcome. Similarly, when we asked our members what they found appealing about the idea of trying a GLP-1, they used terms like kickstart, jumpstart, and boost, all of which we believe suggests our members may view medication as short-term support on a long-term journey